BD (NYSE:BDX) announced today that it launched its Pyxis Pro Dispensing Solution and Incada Connected Care Platform in Europe ...
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results